|
Depressive disorder
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
The Association between DRD3 Ser9Gly Polymorphism and Depression Severity in Parkinson's Disease.
|
31143436 |
2019 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
BEFREE |
The aim of the present study was to examine the role of DRD3 in the anxiety-like and depression-like behavioral changes induced by estrogen and progesterone.
|
30292827 |
2019 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
PSYGENET |
The aim of the present study was to examine the role of dopamine D3 receptor on the anxiety-like and depression-like behaviors induced by immobilization stress.
|
23357086 |
2013 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
PSYGENET |
Direct associations were identified between the dopamine receptor 3 (DRD3) BalI polymorphism and depression; the dopamine receptor 1 (DRD1) and dopamine transporter gene 3' VNTR polymorphisms and aberrant motor behavior; the DRD4 VNTR and sleep disturbances; and the SERT gene VNTR 5HTTLPR and apathy items.
|
20685009 |
2012 |
|
Depressive disorder
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Direct associations were identified between the dopamine receptor 3 (DRD3) BalI polymorphism and depression; the dopamine receptor 1 (DRD1) and dopamine transporter gene 3' VNTR polymorphisms and aberrant motor behavior; the DRD4 VNTR and sleep disturbances; and the SERT gene VNTR 5HTTLPR and apathy items.
|
20685009 |
2012 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
PSYGENET |
Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).
|
21630437 |
2011 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
BEFREE |
Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).
|
21630437 |
2011 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
PSYGENET |
Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
|
19235789 |
2009 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
BEFREE |
Associations were revealed between DRD3 and elation, and between DRD4 with agitation/aggression and with depression; however, these findings do not remain significant after correction for multiple testing.
|
19235789 |
2009 |
|
Depressive disorder
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3).
|
17851196 |
2007 |
|
Depressive disorder
|
0.360 |
Biomarker
|
disease |
PSYGENET |
Depression and psychotic symptoms that occur in a large proportion of AD patients have been associated with monoamine genes coding for metabolic enzymes (COMT), transporters (5-HTTLPR) and receptors (DRD1; DRD3).
|
17851196 |
2007 |